NCT04172532 2026-06-02Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic CancerNational Cancer Institute (NCI)Phase 1/2 Recruiting92 enrolled